Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Antaria is an Australian pharmaceutical manufacturing company and trading subsidiary associated with Advance ZincTek that produces cosmetic- and pharmaceutical-grade non-nano zinc oxide ingredients for mineral sunscreens, skin protection, and personal care products. Its products are sold commercially under the ZinClear brand family and are supplied globally through warehouses and distributor networks in Australia, the United States, Europe, and other markets. The company operates under TGA requirements and GMP certification and positions zinc oxide as a broad-spectrum UV-protection active used by sunscreen and skincare brands. Antaria appears to be a commercial-stage specialty ingredient supplier rather than a therapeutic drug developer, with business activity centered on manufacturing and distribution of zinc oxide raw materials rather than a clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Antaria.